IatroQuest Corporation
Biosensing technology company
About IatroQuest Corporation
IatroQuest Corporation, founded in 1998, operated from Ottawa, Ontario, Canada as a biosensing technology company within the biotechnology and deep diagnostics sectors. The company was established by co-founders Dr. David Armstrong and Dr. Martine Lafrance. IatroQuest emerged as a spin-off from the National Research Council, receiving assistance from the Ottawa branch of Inno-Centre.
The core of IatroQuest's business was its Bio-Alloy technology, a bio-photonic platform designed for the detection of biological and chemical agents. This technology utilized biosensing modules, including micro-array biochip formats, to identify bacteria, viruses, and toxins in real-time with a high degree of sensitivity. The company positioned its offerings as Original Equipment Manufacturer (OEM) products aimed at a diverse client base across military, civilian, and medical markets.
A significant milestone occurred in October 2001, when IatroQuest secured a $4.8 million private placement to advance the development of its Bio-Alloy platform. This funding round was supported by a consortium of investors, including Investissement Desjardins, the Business Development Bank of Canada, and T2C2 Bio 2000, alongside several private investors. Following this investment, Jean Bourbonnais was appointed as the new President and CEO, with the founders continuing in executive roles: Dr. David Armstrong as Executive VP of Innovation and Regulatory Affairs and Dr. Martine Lafrance as Chief Technology Officer. Although the company showed early promise, its operating status is now listed as inactive.
Source: Dealroom company dataNews
Open roles
IatroQuest Corporation in the Ottawa ecosystem
The IatroQuest Corporation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- TCT2C2 Capital
Desjardins Group
Fonds de solidarité FTQ
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about IatroQuest Corporation on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IatroQuest Corporation on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

